Literature DB >> 24101317

Hemangioblastoma of the filum terminale associated with von Hippel-Lindau disease: a case report.

Bulent Tucer1, Mehmet Ali Ekici, Burak Kazanci, Bulent Guclu.   

Abstract

We report a 41-year-old man who presented with low back pain, lower extremity paresthesia, urinary retention and constipation. Magnetic resonance imaging showed a vascular intradural-extramedullary lesion at the second lumbar vertebral level. His medical history revealed that he had undergone surgery for a cerebellar hemangioblastoma 5 years ago. The patient underwent a spinal operation and a vascular tumor was removed from filum terminale. Pathologic examination of the tumor revealed a hemangioblastoma. Hemangioblastomas may occur sporadically or in association with von Hippel-Lindau disease. In the second case, they are often multiple and accompanied by cerebellar and brainstem lesions. The hemangioblastomas reported in the conus medullaris or in the extramedullary compartment adjacent to the conus medullaris are rare, tumors of the cauda equina are uncommon, and lesions of the filum terminale are extremely rare. We report a patient with von Hippel-Lindau disease having filum terminale hemangioblastoma and discuss the diagnosis, pathogenesis and treatment of hemangioblastoma.

Entities:  

Mesh:

Year:  2013        PMID: 24101317     DOI: 10.5137/1019-5149.JTN.6172-12.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  2 in total

1.  Intradural, extramedullary hemangioblastoma at the level of the conus medullaris: illustrative case.

Authors:  Lisa B E Shields; John E Harpring; Hilary A Highfield; Yi Ping Zhang; Christopher B Shields
Journal:  J Neurosurg Case Lessons       Date:  2021-04-26

2.  Monoradiculopathy Caused by Sporadic Hemangioblastoma of the Conus Medullaris: Case Report and Literature Review.

Authors:  Ivo Kehayov; Polina Angelova; Ivan Batakliev; Veselin Belovezhdov; Borislav Kitov
Journal:  Cureus       Date:  2022-04-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.